Allarity Therapeutics Inc (ALLR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,472 | -3,843 | -11,901 | -10,179 | -5,732 |
| Depreciation Amortization | 3 | 2 | 37 | 28 | 19 |
| Income taxes - deferred | N/A | -14 | 97 | N/A | N/A |
| Accounts payable and accrued liabilities | -573 | 2,838 | 2,165 | 96 | 1,838 |
| Other Working Capital | -687 | 2,887 | 3,352 | -126 | 1,690 |
| Other Operating Activity | -1,974 | -3,269 | -6,495 | -892 | -3,512 |
| Operating Cash Flow | $-8,703 | $-1,399 | $-12,745 | $-11,073 | $-5,697 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,340 | 1,340 | 1,050 | N/A | 1,050 |
| Debt Repayment | -1,340 | N/A | -3,699 | -3,698 | -3,348 |
| Common Stock Issued | 27,689 | 40 | 16,895 | 18,615 | 6,815 |
| Other Financing Activity | 0 | 0 | -3,251 | -4,444 | -494 |
| Financing Cash Flow | $27,689 | $1,380 | $10,995 | $10,473 | $4,023 |
| Exchange Rate Effect | 81 | 165 | -113 | -30 | 65 |
| Beginning Cash Position | 166 | 166 | 2,029 | 2,029 | 2,029 |
| End Cash Position | 19,233 | 312 | 166 | 1,399 | 420 |
| Net Cash Flow | $19,067 | $146 | $-1,863 | $-630 | $-1,609 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,703 | -1,399 | -12,745 | -11,073 | -5,697 |
| Free Cash Flow | -8,703 | -1,399 | -12,745 | -11,073 | -5,697 |